ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,896, issued on Nov. 11, was assigned to Genentech Inc. (South San Francisco, Calif.).
"Anti-CD3 antibodies and methods of use" was invented by Xiaocheng Chen (Foster City, Calif.), Mark S. Dennis (San Carlos, Calif.), Allen J. Ebens Jr. (San Carlos, Calif.), Robert F. Kelley (Petaluma, Calif.), Mary A. Mathieu (San Francisco) and Liping L. Sun (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides anti-cluster of differentiation 3 (CD3) antibodies and methods of using the same."
The patent was filed on Sept. 6, 2022, under Application No. 17/930,018.
*For further information, including images, charts and...